Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy

MeSH terms

• Adult
• Age Factors
• Aged
• Aged, 80 and over
• Anticoagulants / adverse effects
• Anticoagulants / therapeutic use*
• Coronary Disease / complications
• Coronary Disease / diagnosis
• Coronary Disease / drug therapy*
• Coronary Disease / mortality
• Electrocardiography
• Female
• Fibrinolytic Agents / adverse effects
• Fibrinolytic Agents / therapeutic use*
• Hemorrhage / chemically induced*
• Heparin / adverse effects
• Heparin / therapeutic use*
• Humans
• Linear Models
• Logistic Models
• Male
• Middle Aged
• Myocardial Infarction / etiology
• Myocardial Infarction / mortality
• Patient Selection
• Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
• Prognosis
• Risk Factors
• Safety
• Time Factors
• Tirofiban
• Treatment Outcome
• Tyrosine / adverse effects
• Tyrosine / analogs & derivatives
• Tyrosine / therapeutic use*